Stockreport

ImmunityBio (IBRX) Reports 700% Revenue Surge Driven by Rapid ANKTIVA Adoption [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF ImmunityBio (IBRX) Reports 700% Revenue Surge Driven by Rapid ANKTIVA Adoption [Read more]